These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8080496)

  • 1. Risk of secondary cutaneous malignancies in patients with long-standing mycosis fungoides.
    Smoller BR; Marcus R
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):201-4. PubMed ID: 8080496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides.
    Abel EA; Sendagorta E; Hoppe RT
    J Am Acad Dermatol; 1986 Jun; 14(6):1029-38. PubMed ID: 3722479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal squamous cell carcinoma following whole body electron beam therapy and photochemotherapy for mycosis fungoides.
    Wright S; Kennedy C
    Clin Exp Dermatol; 1984 Jan; 9(1):53-7. PubMed ID: 6420097
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
    Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real-life experience from a single tertiary center.
    Doğan PE; Akay BN; Vural S; Arı C; Yılmaz TE; Şanlı H
    Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):428-434. PubMed ID: 36967646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern therapy of mycosis fungoides].
    Roenigk HH
    Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
    Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
    J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.
    Wu PA; Huang V; Bigby ME
    Br J Dermatol; 2014 May; 170(5):1015-20. PubMed ID: 24841586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total Skin Electron Irradiation and Sequential Malignancies in Mycosis Fungoides Patients: Longitudinal Study.
    Lutsyk M; Ben-Yosef R; Bergman R; Kuten A; Bar-Sela G
    Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):618-624. PubMed ID: 29945743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy.
    Price NM; Hoppe RT; Constantine VS; Fuks ZY; Farber EM
    Cancer; 1977 Dec; 40(6):2851-3. PubMed ID: 412580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M; Lemak NA; Redman JR; Eifel PJ; Tucker SL; Cabanillas FF; Kurzrock R
    J Am Acad Dermatol; 1996 Jun; 34(6):1022-9. PubMed ID: 8647968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
    Huang J; Cowper S; Moss J; Girardi M
    J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The head and neck manifestations of mycosis fungoides.
    Brennan JA
    Laryngoscope; 1995 May; 105(5 Pt 1):478-80. PubMed ID: 7760661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
    Hamminga B; Noordijk EM; van Vloten WA
    Arch Dermatol; 1982 Mar; 118(3):150-3. PubMed ID: 7065660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
    Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
    Herrmann JJ; Roenigk HH; Hurria A; Kuzel TM; Samuelson E; Rademaker AW; Rosen ST
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):234-42. PubMed ID: 7622650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous malignant melanoma appearing during photochemotherapy of mycosis fungoides.
    Reseghetti A; Tribbia G; Locati F; Naldi L; Marchesi L
    Dermatology; 1994; 189(1):75-7. PubMed ID: 8003794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
    Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
    Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.